Recerca

Àrea 3

Oncologia Hepàtica

Articles de l'any 2010
Original

Originals publicats: 11

Factor d'impacte: mitjana: 5.66, total: 62.23

  • The use of beta-adrenergic drugs improves hepatic oxygen metabolism in cirrhotic patients undergoing liver resection

    Taura P, Fuster J, Mercadal J, Martinez-Palli G, Fondevila C, Blasi A, Balust J, Garcia-Valdecasas JC
    J HEPATOL. 2010; 52: 340-347. IF: 7.818

  • IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage

    Tovar V, Alsinet C, Villanueva A, Hoshida Y, Chiang DY, Sole M, Thung S, Moyano S, Toffanin S, Minguez B, Cabellos L, Peix J, Schwartz M, Mazzaferro V, Bruix J, Llovet JM
    J HEPATOL. 2010; 52: 550-559. IF: 7.818

  • Portal Hyperperfusion: Mechanism of Injury and Stimulus for Regeneration in Porcine Small-for-Size Transplantation

    Fondevila C, Hessheimer AJ, Taura P, Sanchez O, Calatayud D, DeRiva N, Munoz J, Fuster J, Rimola A, Garcia-Valdecasas JC
    LIVER TRANSPLANT. 2010; 16: 364-374. IF: 3.724

  • Combined liver-kidney transplantation in patients with cirrhosis and chronic kidney disease

    Baccaro ME, Pepin MN, Guevara M, Colmenero J, Torregrosa JV, Martin-Llahi M, Sola E, Esforzado N, Fuster J, Campistol JM, Arroyo V, Navasa M, Garcia-Valdecasas J, Gines P
    NEPHROL DIAL TRANSPL. 2010; 25: 2356-2363. IF: 3.306

  • A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma

    Greten TF, Forner A, Korangy F, N'kontchou G, Barget N, Ayuso C, Ormandy LA, Manns MP, Beaugrand M, Bruix J
    BMC CANCER. 2010; 10: 0-0. IF: 2.736

Revisió

Revisions publicades: 6

Factor d'impacte: mitjana: 6.67, total: 40.02

  • Hepatocellular Carcinoma: Novel Molecular Approaches for Diagnosis, Prognosis, and Therapy

    Villanueva A, Minguez B, Forner A, Reig M, Llovet JM
    ANNU REV MED. 2010; 61: 317-328. IF: 9.94

  • Cancer gene discovery in hepatocellular carcinoma

    Zender L, Villanueva A, Tovar V, Sia D, Chiang DY, Llovet JM
    J HEPATOL. 2010; 52: 921-929. IF: 7.818

Editorials

Editorials publicades: 9

Factor d'impacte: mitjana: 12.06, total: 108.53

  • Ablation for hepatocellular carcinoma: Is there need to have a winning technique?

    Forner A, Bruix J
    J HEPATOL. 2010; 52: 310-312. IF: 7.818

  • Treating hepatitis C in patients with cirrhosis: The effort is worth it

    Forns X, Bruix J
    J HEPATOL. 2010; 52: 624-626. IF: 7.818

Multicèntrics

Multicèntrics publicats: 1

Factor d'impacte: mitjana: 28.9, total: 28.9

  • Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer A Meta-analysis

    Paoletti X, Oba K, Burzykowski T, Michiels S, Ohashi Y, Pignon JP, Rougier P, Sakamoto J, Sargent D, Sasako M, VanCutsem E, Buyse M
    JAMA-J AM MED ASSOC. 2010; 303: 1729-1737. IF: 28.899

Guies clíniques

Guies clínique publicades: 1

Factor d'impacte: mitjana: 2.21, total: 2.21

  • Hepatocellular Carcinoma (HCC) A Global Perspective

    Ferenci P, Fried M, Labrecque D, Bruix J, Sherman M, Omata M, Heathcote J, Piratsivuth T, Kew M, Otegbayo JA, Zheng SS, Sarin S, Hamid SS, Modawi SB, Fleig W, Fedail S, Thomson A, Khan A, Malfertheiner P, Lau G, Carillo FJ, Krabshuis J, LeMair A
    J CLIN GASTROENTEROL. 2010; 44: 239-245. IF: 2.207

Més articles
Tesis
  • Actitud a seguir ante la detección de una lesión focal inferior o igual a 2 cm de tamaño en un paciente con cirrosis hepática.

    Doctorand: Alejandro Forner Gonzalez,
    Director/s: Bruix J